If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Gabriele Madonna is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Melanoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Mutation Medicine & Life Sciences
Matrix Metalloproteinase 9 Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Natural Killer Cells Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Electrochemotherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2019

  • 310 Citations
  • 9 h-Index
  • 21 Article
  • 1 Letter

Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway

Cristiani, C. M., Turdo, A., Ventura, V., Apuzzo, T., Capone, M., Madonna, G., Mallardo, D., Garofalo, C., Giovannone, E. D., Grimaldi, A. M., Tallerico, R., Marcenaro, E., Pesce, S., Zotto, G. D., Agosti, V., Costanzo, F. S., Gulletta, E., Rizzo, A., Moretta, A., Karre, K. & 3 others, Ascierto, P. A., Todaro, M. & Carbone, E., May 2019, In : Cancer immunology research. 7, 5, p. 841-852 12 p.

Research output: Contribution to journalArticle

Natural Killer Cells
Melanoma
Galectins
Neoplastic Stem Cells
T-Lymphocyte Subsets

Automatic discovery of image-based signatures for ipilimumab response prediction in malignant melanoma

Harder, N., Schönmeyer, R., Nekolla, K., Meier, A., Brieu, N., Vanegas, C., Madonna, G., Capone, M., Botti, G., Ascierto, P. A. & Schmidt, G., Dec 1 2019, In : Scientific Reports. 9, 1, 7449.

Research output: Contribution to journalArticle

Open Access
Routine Diagnostic Tests
Melanoma
Tumor-Infiltrating Lymphocytes
Decision Trees
Precision Medicine
1 Citation (Scopus)

First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis

Schilling, B., Martens, A., Geukes Foppen, M. H., Gebhardt, C., Hassel, J. C., Rozeman, E. A., Gesierich, A., Gutzmer, R., Kähler, K. C., Livingstone, E., Diamantopoulos, P. T., Gogas, H., Madonna, G., Ascierto, P. A., Goldinger, S. M., Mangana, J., Garbe, C., Schadendorf, D., Blank, C. & Weide, B., Jan 1 2019, In : Cancer Immunology, Immunotherapy.

Research output: Contribution to journalArticle

Melanoma
Death Domain Receptors
Survival
Mitogen-Activated Protein Kinases
Therapeutics
Melanoma
Neutrophils
Lymphocytes
Survival
Disease-Free Survival

CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab

Queirolo, P., Dozin, B., Morabito, A., Banelli, B., Carosio, R., Fontana, V., Ferrucci, P. F., Martinoli, C., Cocorocchio, E., Ascierto, P. A., Madonna, G., Simeone, E., De Galitiis, F., Antonini Cappellini, G. C., Marchetti, P., Guida, M., Tommasi, S., Ghilardi, L., Merelli, B., Fava, P. & 7 others, Osella-Abate, S., Guidoboni, M., Romani, M., Ferone, D., Spagnolo, F., Pistillo, M. P. & (IMI), I. M. I., 2018, In : European journal of cancer. 97, p. 59-61 3 p.

Research output: Contribution to journalArticle